@FierceMedDev: EarlySense in Israel raised $15M for hospital beds with sensors built in. Via Globes. More | Follow @FierceMedDev
@MarkHFierce: HeartWare boosted revenue in Q3 2012, thanks to expanded Int'l approval for its HVAD device. But net losses soared. More | Follow @MarkHFierce
@DamianFierce: Covance took a 7% profit hit in Q3 but still topped Wall Street estimates. More | Follow @DamianFierce
> SetPoint Medical generated positive clinical results for a first-in-human study using a neuromodulation device to treat rheumatoid arthritis. Item
> ConforMIS, an orthopedic implant device maker, has hired veteran Genzyme executive Peter Traynor as its new chief financial officer. Item
> California-based Presbia has submitted an investigational device exemption with the FDA for an implantable microlens designed to treat presbyopia, the age-related loss of near vision. Item
> Sapiens ($SPNS) is leading a new collaborative European project focused on developing a new patient-specific approach for deep brain stimulation therapy for Parkinson's disease patients. Release
> Roche ($RHHBY) has launched an additional diagnostic test designed to help better manage patients with epithelial ovarian cancer. Release
> AdvaMed is debuting a new web portal that links veterans seeking nobs to med tech-related mentors and recruiters. Item
Biotech News
@FierceBiotech: From FierceCRO.com: Icon launches new functional service model. More | Follow @FierceBiotech
@JohnCFierce: How about that--AstraZeneca gets pos. data in late-stage constipation study. Partnered with Nektar ('09 1.5B deal). More | Follow @JohnCFierce
@RyanMFierce: Boehringer Ingelheim takes hepC message online. News | Follow @RyanMFierce
> CV fears cloud AstraZeneca's positive results for $1.5B constipation program. Article
> Abbott, Gilead impress with upbeat results for oral hep C drugs. Report
> Shares of Clovis, Clavis blasted by failure of pancreatic cancer drug. Story
> Tau theory comes center stage in Alzheimer's R&D as amyloid advocates regroup. News
Pharma News
@FiercePharma: In $491mn Rapamune settlement, Pfizer to plead guilty to a misdemeanor. News | Follow @FiercePharma
> Pfizer racks up $600M-plus in Wyeth-related legal settlements. Report
> Sistema aims to buy Russia's Veropharm in potential $636M deal. Article
> Pfizer under fire in U.K. for paying little-to-no corporate tax. Story
Biotech IT News
> GNS turns to Big Data to crack multiple myeloma. News
> FDA updates IT after GAO lashing. Item
> Boehringer Ingelheim takes hep C message online. Article
> Private equity interest in Merge prompts breakup speculation. Story
> Maverix enters genomics software game with Silicon Valley sizzle. Report
CRO News
> Parexel looks to the future with university partnership. Item
> Covance posts profit drop but beats predictions in Q3. Story
> DiscoveRx snags BioSeek for drug development. News
> CRA buys Radiant Research to increase trial capacity. Article
> AMRI narrows losses on strong Q3. News